Document:

Exhibit 10.6

INDEX PRODUCT LICENSE AGREEMENT

          This
Product License Agreement (“PLA”), entered into pursuant to Section 1.2 of that
certain August 23, 2010 Morningstar Master License Agreement (“Master
Agreement”) by and between Morningstar, Inc. (“Licensor”) and Van Eck
Associates Corporation(“Licensee”), the terms of which Master Agreement are
incorporated herein in their entirety by reference to form the agreement
(“Agreement”) between Licensor and Licensee with respect to the below-defined
Products, is executed and effective as of this 16th day of April
2012 (“PLA Effective Date”). In the event the Master Agreement expires or
terminates for any reason, this Agreement shall automatically terminate and,
except as provided herein or in the Master Agreement, all rights and
obligations of the parties hereunder shall simultaneously terminate. 

          Licensor
and Licensee agree, as follows: 

	
 

	
 

	
1.

	
Limited License. Licensor hereby grants to
Licensee a nontransferable limited U.S.-only license to use: (a) the
Morningstar® Long/Flat Commodity IndexSM and (b) the Morningstar® Long/Short Commodity IndexSM (each, a “Product” and
together, the “Products”) as designated on Attachment A, a copy of which is
attached hereto and incorporated by reference, and created in accordance with
versions of the Rule Book listed in Section 7 below and such future versions
of the Rule Book as Licensor may subsequently implement from time to time at
its discretion; (b) those Licensor marks set forth in Section 8 (collectively,
the “Morningstar Marks”); and (c) the Licensor documentation, research and
materials in the field of Licensor’s index business that Licensor may furnish
to Licensee from time to time, including, without limitation, those materials
set forth in Section 7 (all such documentation, research and materials,
collectively, the “Intellectual Property”) all solely for the specific
purpose of Licensee using the Products to create a single Exchange Traded
Fund for each Product (each, an “ETF” and together, the “ETFs”). For purposes
of this PLA, an ETF is a pooled investment vehicle, fund, trust, investment
company or other similar product (i) that issues, sells, and redeems blocks
of shares, units, or similar interests and (ii) whose shares, units or
similar interests trade on national securities exchanges (such as the New
York Stock Exchange) or other secondary market facilities. Licensee intends
to use the Products in ETFs sponsored or advised by Licensee or an affiliate
of Licensee (each such ETF, hereafter, a “Licensee Product” and together, the
“Licensee Products”). Notwithstanding the foregoing and for the avoidance of
doubt, the parties acknowledge and agree that the ETFs may be marketed and
sold worldwide but that Licensor makes no warranty of non-infringement with
respect to the Products or the Intellectual Property other than with respect
to any U.S.-based intellectual property rights.  

	
 

	
 

	
2.

	
Licensee’s Product Commitments. If it has
not already done so, Licensee shall submit a registration statement for at
least one of the Licensee Products to one or more U.S. regulatory authorities
(e.g., the U.S. Securities and Exchange Commission) (each, a “Regulatory
Authority”) within sixty (60) days of the PLA 

	
 

	
 

	
 

	
 

	
Effective
Date and will make at least one of the Licensee Products available for sale
to investors in the U.S. within one hundred twenty (120) days of
effectiveness of such registration statement. Except as provided in this
Agreement, Licensee will have no obligation hereunder to create or maintain
the Licensee Products, nor will Licensee have an obligation to maintain any
particular level of assets in the Licensee Products. Licensee, in its sole
discretion, may determine to liquidate, dissolve, or otherwise discontinue
the Licensee Products; provided that Licensee’s obligations under this
Agreement including, without limitation, the obligation to pay the License
Fees for the Term (as defined below), will remain in full force and effect.

	
 

	
 

	
 

	
 

	
For purposes
of this PLA, the “Launch Date” shall be deemed to be the earlier of: (i) the
date that is one hundred eighty (180) days after the PLA Effective Date; or
(ii) the date on which the securities of the first Licensee Product are first
made available for sale to investors in the United States (the date referred to
in this clause (ii), the “Product Launch Date”). The first Licensee Product
sponsored or advised by Licensee or its affiliate as contemplated by this PLA
that is made available for sale to investors in the United States is referred
to herein as the “first Licensee Product” and the second Licensee Product
sponsored or advised by Licensee or its affiliate as contemplated by this PLA
made available for sale to investors in the United States following the first
Licensee Product is referred to herein as the “second Licensee Product”.

	
 

	
 

	
 

	
3.

	
Term. The initial term of this Agreement
(“Initial Term”) is three (3) years’ from the PLA Effective Date. After the
Initial Term, this Agreement will automatically renew for successive periods
of one (1) year each, unless either party provides the other party with
written notice of its intent not to renew no less than ninety (90) days prior
to the end of the term for which termination is sought. 

	
 

	
 

	
 

	
 

	
Notwithstanding
anything to the contrary herein, if, on or after the twelve-month anniversary
of the PLA Effective Date, Licensee determines that, due to legal or
regulatory reasons (including, without limitation, a prolongation in the time
required for a registration statement in respect of a Licensee Product to
become effective), it is not practicable to launch a Licensee Product,
Licensee shall have the right to terminate this Agreement upon at least 30
days’ prior written notice to Licensor.

	
 

	
 

	
4.

	
License Fees

	
 

	
The License
Fees payable by Licensee hereunder with respect to its use of the Products
shall begin to accrue as of the Launch Date. License Fees shall be paid
quarterly in arrears.

	
 

	
 

	
 

	
(a)

	
During each
year of the Initial Term or any extension thereof (collectively, the “Term”),
commencing on the Launch Date and ending on the date on which the securities
of the second Licensee Product are first made available for sale to investors
in the United States (at which point, for the 

2

	
 

	
 

	
 

	
 

	
 

	
 

	
avoidance of
doubt, the License Fees payable by Licensee shall be calculated as set forth
in Section 4(b) below), Licensee will be obligated to pay Licensor the
greater of (i) hundred and fifty thousand dollars ($150,000) and (ii) the
following variable fees, based on the total number of assets held in the
Licensee Products:

	
 

	
 

	
 

	
 

	
 

	
 

	
i)

	
Asset-Breakpoint
1: Licensee shall pay an annual fee equal to twenty percent (20%) of its
management fee as disclosed in the prospectus for the first Licensee Product
(the “First Management Fee”) on the average daily net assets of the first
Licensee Product during such quarter up to 1 billion USD; 

	
 

	
 

	
ii)

	
Asset-Breakpoint
2: Licensee shall pay an annual fee equal to seventeen-and-a-half percent
(17.5%) of the First Management Fee on the average daily net assets of the
first Licensee Product during such quarter of more than 1 billion USD up to a
maximum of 2 billion;

	
 

	
 

	
iii)

	
Asset
Breakpoint 3: Licensee shall pay an annual fee equal to fifteen percent (15%)
of the First Management Fee on the average daily net assets of the first
Licensee Product during such quarter of more than 2 billion USD up to a
maximum of 3 billion USD;

	
 

	
 

	
iv)

	
Asset
Breakpoint 4: Licensee shall pay an annual fee equal to twelve-and-a-half
percent (12.5%) of the First Management Fee on the average daily net assets
of the first Licensee Product during such quarter of more than 3 billion USD
up to a maximum of 4 billion USD; and

	
 

	
 

	
v)

	
Asset
Breakpoint 5: Licensee shall pay an annual fee equal to ten percent (10%) of
the First Management Fee on the average daily net assets of the first Licensee
Product during such quarter in excess of 4 billion USD.

	
 

	
 

	
 

	
 

	
 

	
(b)

	
During the
Term, commencing on the date on which the securities of the second Licensee
Product are first made available for sale to investors in the United States,
Licensee will be obligated to pay Licensor the greater of (i) two hundred
thousand dollars ($200,000) or (ii) the following variable fees: 

	
 

	
 

	
 

	
 

	
 

	
i)

	
Asset-Breakpoint
1: Licensee shall pay an annual fee equal to the sum of (x) twenty percent
(20%) of the First Management Fee on the average daily net assets of the
first Licensee Product during such quarter (the “First Product Net Asset
Calculation”) and (y) twenty percent (20%) of its management fee as disclosed
in the prospectus for the second Licensee Product (the “Second Management
Fee”) on the average daily net assets of the second Licensee Product during
such quarter (the “Second Product Net Asset Calculation”); provided, that the
sum of the assets of the First Licensee Product and the assets of the Second
Licensee Product is equal to or less than 1 billion USD;

3

	
 

	
 

	
 

	
 

	
 

	
 

	
ii)

	
Asset-Breakpoint
2: Licensee shall pay an annual fee equal to the sum of (x)
seventeen-and-a-half percent (17.5%) of the First Management Fee on the First
Product Net Asset Calculation and (y) seventeen-and-a-half percent (17.5%) of
the Second Management Fee on the Second Product Net Asset Calculation;
provided, that the sum of the assets of the First Licensee Product and the
assets of the Second Licensee Product is greater than 1 billion USD but less
than 2 billion USD; 

	
 

	
 

	
iii)

	
Asset
Breakpoint 3: Licensee shall pay an annual fee equal to the sum of (x)
fifteen percent (15%) of the Management Fee on the First Product Net Asset
Calculation and (y) fifteen percent (15%) of the Second Management Fee on the
Second Product Net Asset Calculation; provided, that the assets of the First
Licensee Product and the assets of the Second Licensee Product is greater
than 2 billion USD but less than 3 billion USD; 

	
 

	
 

	
iv)

	
Asset
Breakpoint 4: Licensee shall pay an annual fee equal to the sum of (x)
twelve-and-a-half percent (12.5%) of the First Management Fee on the First
Product Net Asset Calculation and (y) twelve-and-a-half percent (12.5%) of
the Second Management Fee on the Second Product Net Asset Calculation; provided,
that the sum of the assets of the First Licensee Product and the assets of
the Second Licensee Product is greater than 3 billion USD but less than 4
billion USD; and 

	
 

	
 

	
v)

	
Asset
Breakpoint 5: Licensee shall pay an annual fee equal to the sum of ten
percent (10%) of the First Management Fee on the First Product Net Asset
Calculation and (y) ten percent (10%) of the Second Management Fee on the
Second Product Net Asset Calculation; provided, that the sum of the assets of
the First Licensee Product and the assets of the Second Licensee Product is
greater than 4 billion USD. 

	
 

	
 

	
 

	
 

	
 

	
(c)

	
Notwithstanding
anything to the contrary herein, Licensor shall reimburse Licensee 25% of the
fee minimum set forth in this Section 4 in the event that the first Licensee
Product is not launched within 180 days of the PLA Effective Date through no
fault of Licensee or its agents as long as the first Licensee Product is
launched within 12 months of the PLA Effective Date. 

	
 

	
 

	
5.

	
Exclusivity Period

	
 

	
Subject to
the terms and conditions contained in this PLA and the Agreement, Licensee
will have exclusive rights to use the Products and the Intellectual Property
in the United States in connection with the operation of the Licensee
Products beginning on the PLA Effective Date and continuing for a period of
one (1) year after the Launch Date of the relevant Licensee Product (the
“Initial Exclusivity Period”). During the Initial Exclusivity Period,
Licensor will not license the Products or a non-material derivation of the
Products in the United

4

	
 

	
 

	
 

	
 

	
 

	
States to
any other party (other than Licensor’s affiliated companies) that intends to
list ETFs based upon the Products.

	
 

	
 

	
 

	
 

	
 

	
The Initial
Exclusivity Period may be extended for up to two (2) additional years’ time
if the total gross asset under management associated with the Licensee
Products meet the following hurdles on the following dates:

	
 

	
 

	
 

	
 

	
 

	
 

	
a)

	
500 million
USD on the first anniversary of the Product Launch Date of the first Licensee
Product; and 

	
 

	
 

	
b)

	
1 billion
USD on the second anniversary of the Product Launch Date of the first
Licensee Product. 

	
 

	
 

	
 

	
 

	
 

	
If (i)
Licensee fails to launch the first Licensee Product within 12 months of the
PLA Effective Date and/or (ii) Licensee fails to meet any of these AUM
hurdles as of the dates set forth above, Licensor will have the right at any
time thereafter to terminate Licensee’s exclusivity with respect to the
Products and Intellectual Property on at least thirty (30) days’ written
notice to Licensee and to continue to license the Products and Intellectual
Property to Licensee on a non-exclusive basis for the remainder of the Term.

	
 

	
 

	
 

	
If Licensee
launches the first Licensee Product in a timely manner as contemplated by
this PLA but fails to launch the second Licensee Product within 12 months of
the PLA Effective Date, Licensor will have the right to terminate Licensee’s
exclusivity with respect to the second Licensee Product on at least thirty
(30) days’ written notice to Licensee and Licensor shall continue to license
such Product and Intellectual Property to Licensee on a non-exclusive basis
for the remainder of the Term.

	
 

	
 

	
6.

	
Right of First Refusal

	
 

	
In the event
that a third party approaches Licensor after the PLA Effective Date through
the six-month period following the Launch Date of the first Licensee Product
and such third party has a bona fide interest in licensing the Product for
use in creating an investment vehicle for the European market, Licensor
agrees to provide Licensee with a right of first refusal to separately
license the Product to develop and market Licensee Products for the European
market. The licensing terms for this separate arrangement will not be
governed by this Agreement but will instead be negotiated separately pursuant
to a separate product license agreement under the Master License. In the
event of such bona fide third party interest within the above-referenced
six-month time period, Licensor will promptly notify Licensee and Licensee
will then have 14 days to respond to Licensor’s notice. In case Licensee
decides to exercise its right of first refusal hereunder, Licensor will
provide Licensee with an exclusive license to use the Product to develop and
market one or more Licensee Products for the European market for a time
period of at least 180 days from its launch of the first Licensee Product in
any European market; provided that Licensee follows the same registration
application and Licensee Product launch deadlines applicable to its

5

	
 

	
 

	
 

	
creation and
distribution of the first Licensee Product in the U.S; and provided further,
that any grant of exclusive license may, at Licensor’s discretion, except out
those third parties to whom Licensor had already been in discussions at the
time Licensee provided Licensor with notice of Licensee’s intent to exercise
its right of first refusal.

	
 

	
 

	
7.

	
Exchange & Specialist

	
 

	
To the
extent the Licensee Products are listed for trading on an exchange, Licensee
has the authority to decide the specialists and listing venues in the U.S.A
for the Licensee Products and will not require any further license from
Licensor to affect such listing. Licensor agrees to grant the exchanges
designated by Licensee no-fee licenses for the purpose of allowing such
exchanges in the U.S.A to list and facilitate trading in the Licensee
Products. In the event that Licensee desires to list one or more Licensee
Products for trading on an exchange outside of the United States, Licensee
may request in writing that Licensor allow such a listing. Licensor reserves
the right in its sole discretion to deny such request or to impose additional
conditions on Licensee in exchange for Licensor’s approval.

	
 

	
 

	
8.

	
Data Requirements

	
 

	
Licensor
will provide Licensee with the Products’ related data points (“Product Data”)
set forth in Attachment A on the time frames set forth therein. Licensee may
use these Product Data solely in connection with the operation, distribution
and marketing of the Licensee Products.

	
 

	
 

	
 

	
Licensor
will provide its real time pricing of the Products to external vendors and
Licensee as needed to price Licensee Products on an intra day basis and to
calculate an NAV on the Licensee Products. Licensor will share index
statistics and fundamental data (e.g. prices of underlying assets) with
Licensee for use in marketing of the Licensee Products, including for posting
on Licensee’s website.

	
 

	
 

	
9.

	
Multiple Exchange Listings

	
 

	
If
additional exchanges wish to trade the Licensee Products on a UTP (Unlisted
Trading Privilege) basis, Licensor will grant any necessary or applicable license(s)
and the parties will share any fees related to such licensing equally.

	
 

	
 

	
10.

	
Marketing Support

	
 

	
The parties
will work together in good faith to determine the amount and extent of any
marketing efforts to be performed by them.

	
 

	
 

	
11.

	
Intellectual Property

	
 

	
Licensee may
use and, subject to Licensor’s prior review and approval as more fully set
forth in the Master Agreement, distribute the following Intellectual Property
in conjunction with the Licensee Products:

6

	
 

	
 

	
 

	
 

	
 

	
Morningstar
Methodology Rule Book 3.2 for Morningstar Commodity Indexes

	
 

	
 

	
 

	
 

	
 

	
Any
research, marketing or other related materials provided hereunder.

	
 

	
 

	
 

	
12.

	
Morningstar Marks

	
 

	
Subject to
Licensor’s prior review and approval, as more fully set forth in the Master
Agreement, Licensee may use the following Morningstar Marks in conjunction
with its marketing of the Licensee Products:

	
 

	
 

	
 

	
 

	
Morningstar®
Long/Flat Commodity IndexSM

	
 

	
Morningstar®
Long/Short Commodity IndexSM

	
 

	
 

	
 

	
13.

	
Calculation Obligations

	
          Licensor
or its agent(s) shall calculate and publicly disseminate to market data
vendors the value of each Product in a manner and as frequently as may be
required by rules and regulations of any applicable securities exchange (as
such rules and regulations may be amended from time to time) including,
without limitation, Rule 5.2 of NYSE Area Equity Rules.

	
 

	
The Licensee
Products will be named such that the Licensee name will precede that of the
Licensor. Licensee will not include any trademark designators (e.g., TM)
within the name of the Licensee Products.

          The
parties have caused their authorized representatives to execute this PLA as of
the PLA Effective Date. 

	
 

	
 

	
 

	
 

	
 

	
Licensor:

	
 

	
Licensee:

	
Morningstar,
Inc.

	
 

	
Van Eck
Associates Corporation

	
 

	
 

	
 

	
 

	
 

	
By:

	
/s/ SANJAY
ARYA

	
 

	
by:

	
/s/ Wu-Kwan
kit

	
 

	

	
 

	
 

	

	
 

	
SANJAY
ARYA

	
 

	
 

	
Wu-Kwan
kit

	
Title:

	
Senior Vice
President

	
 

	
Title:

	
Assistant
Vice President

7

ATTACHMENT A 

	
 

	
 

	
1)

	
The Products
for which Licensee is receiving a License hereunder is as follows: 

	
 

	
Morningstar®
Long/Flat Commodity IndexSM

	
 

	
Morningstar®
Long/Short Commodity IndexSM

	
 

	
 

	
2)

	
The Product
Data that will be provided to Licensee as part of this License are, as
follows: 

	
 

	
 

	
 

	
 

	
 

	
 

	
A)

	
One time
delivery: daily history of end-of- day Product values from the date of inception
of the Products

	
 

	
B)

	
On a daily basis: 

	
 

	
 

	
i.

	
 

	
A list of Components for
each of the Products;

	
 

	
 

	
ii.

	
 

	
End of day price of each
Component;

	
 

	
 

	
iii.

	
 

	
Divisor of the Product

	
 

	
 

	
iv.

	
 

	
End of Day Product Values

	
 

	
 

	
 

	
 

	
 

	
 

	
 

	
Licensor will provide the
Product Data to Licensee via FTP.

	
 

	
 

	
 

	
 

	
3)

	
Licensor
will advise Licensee of: 

	
 

	
 

	
1.

	
 Changes in
Components; 

	
 

	
 

	
2.

	
 Changes to
the weightings of the Components 

	
 

	
 

	
3.

	
 Changes to
the divisor of the Product

8form8k082012ex10-1.htm

GRIZZLY GOLD CORP.

2012 STOCK OPTION PLAN

ARTICLE 1

PURPOSE OF THE PLAN

This 2012 Stock Option Plan (the “Plan”) is intended to promote the interests of Grizzly Gold Corp., a Nevada corporation, by providing eligible persons in the Corporation’s employ or service with the opportunity to acquire a proprietary interest, or otherwise increase their proprietary interest, in the Corporation as an incentive for them to continue in such employ or service.

ARTICLE 2

DEFINITIONS

2.1           “Board” shall mean the Corporation’s Board of Directors.

2.2           “Code” shall mean the Internal Revenue Code of 1986, as amended, and the Treasury regulations thereunder.

2.3           “Committee” shall mean those persons appointed by the Board to exercise one or more administrative functions under the Plan.

2.4   “Common Stock” shall mean the Corporation’s common stock.

2.5           “Corporate Transaction” shall mean either of the following stockholder approved transactions to which the Corporation is a party:

(i)           an acquisition of any voting securities of the Corporation by any entity or person, immediately after which such entity or person has beneficial ownership of 51% or more of the then outstanding shares or the combined voting power of the Corporation’s then outstanding voting securities;

(ii)           the individuals who, as of the effective date of this Plan are members of the Board (the “Incumbent Board”), cease for any reason to constitute at least two-thirds of the members of the Board; provided, however, that if the election, or nomination of any new director was approved by a vote of at least two-thirds of the Incumbent Board, such new director shall, for purposes of this Plan, be considered as a member of the Incumbent Board;

(iii)           a merger, consolidation or other business combination with or into another company; or

(iv)           the sale or disposition of all or substantially all of the assets of the Corporation.

  

1

  

2.6           “Corporation” shall mean Grizzly Gold Corp., a Nevada corporation, and any successor corporation to all or substantially all of the assets or voting stock of the Corporation which shall by appropriate action adopt the Plan.

2.7           “Disability” shall mean the inability of the Optionee to engage in any substantial gainful activity by reason of any medically determinable physical or mental impairment and shall be determined by the Plan Administrator on the basis of such medical evidence as the Plan Administrator deems warranted under the circumstances.  Disability shall be deemed to constitute permanent Disability in the event that such Disability is expected to result in death or has lasted or can be expected to last for a continuous period of 12 months or more.

2.8           “Employee” shall mean an individual who is in the employ of the Corporation (or any Parent or Subsidiary), subject to the control and direction of the employer entity as to both the work to be performed and the manner and method of performance.

2.9           “Exercise Date” shall mean the date on which the Corporation shall have received written notice of the Option exercise.

2.10           “Fair Market Value” per share of Common Stock on any relevant date shall be determined in accordance with the following provisions:

(a)           If the Common Stock is at the time traded on the Nasdaq National Market, then the Fair Market Value shall be the closing selling price per share of Common Stock on the date in question, as such price is reported by the National Association of Securities Dealers on the Nasdaq National Market.  If there is no closing selling price for the Common Stock on the date in question, then the Fair Market Value shall be the closing selling price on the last preceding date for which such quotation exists.

(b)           If the Common Stock is at the time listed on any Stock Exchange, then the Fair Market Value shall be the closing selling price per share of Common Stock on the date in question on the Stock Exchange determined by the Plan Administrator to be the primary market for the Common Stock, as such price is officially quoted in the composite tape of transactions on such exchange.  If there is no closing selling price for the Common Stock on the date in question, then the Fair Market Value shall be the closing selling price on the last preceding date for which such quotation exists.

(c)           If the Common Stock is at the time neither listed on any Stock Exchange nor traded on the Nasdaq National Market, then the Fair Market Value shall be determined by the Plan Administrator after taking into account such factors as the Plan Administrator shall deem appropriate, consistent with the requirements of Treasury Regulation § 1.422-2(e).

2.11           “Incentive Option” shall mean an Option which satisfies the requirements of Code Section 422.

  

2

  

2.12           “Involuntary Termination” shall mean the termination of the Service of any individual which occurs by reason of:

(a) such individual’s involuntary dismissal or discharge by the Corporation for reasons other than Misconduct, or

 

(b) such individual’s voluntary resignation following: (i) a change in his or her position with the Corporation which materially reduces his or her duties and responsibilities or the level of management to which he or she reports, (ii) a reduction in his or her level of compensation (including base salary, fringe benefits and target bonuses under any corporate-performance based bonus or incentive programs) by more than 15%, or (iii) a relocation of such individual’s place of employment by more than 50 miles; provided and only if such change, reduction or relocation is effected
without the individual’s consent.

 

2.13           “Misconduct” shall mean the commission of any of the following: (i) any act of fraud or embezzlement by the Optionee or Participant, (ii) any unauthorized use or disclosure by such person of confidential information or trade secrets of the Corporation (or any Parent or Subsidiary), or (iii) any other intentional misconduct by such person.  The foregoing definition shall not be deemed to be inclusive of all the acts or omissions which the Corporation (or any Parent or Subsidiary) may consider as grounds for the dismissal or discharge of any
Optionee, Participant or other person in the Service of the Corporation (or any Parent or Subsidiary).

 

2.14  “1934 Act” shall mean the Securities Exchange Act of 1934, as amended.

 

2.15   “Non-Statutory Option” shall mean an Option not intended to satisfy the requirements of Code Section 422.

 

2.16   “Options” shall mean all Incentive Options and/or Non-Statutory Options granted pursuant to the Plan.

 

2.17   “Optionee” shall mean any person to whom an Option is granted under the Plan.

 

2.18   “Parent” shall mean any corporation (other than the Corporation) in an unbroken chain of corporations ending with the Corporation, provided each corporation in the unbroken chain (other than the Corporation) owns, at the time of the determination, stock possessing 50% or more of the total combined voting power of all classes of stock in one of the other corporations in such
chain.

 

2.19   “Plan” shall mean this Grizzly Gold Corp. 2012 Stock Option Plan as set forth in this document, and as amended from time to time.

 

2.20   “Plan Administrator” shall mean either the Board or the Committee acting in its capacity as administrator of the Plan.

 

  

3

  

2.21   “Service” shall mean the provision of services to the Corporation (or any Parent or Subsidiary) by a person in the capacity of an Employee, a non-employee member of the board of directors or a consultant or independent advisor, except to the extent otherwise specifically provided in the documents evidencing the Option grant.

 

2.22   “Stock Exchange” shall mean either the American Stock Exchange, the New York Stock Exchange or the Over the Counter Bulletin Board.

 

2.23   “Stock Option Agreement” shall mean a written agreement between the Corporation and an Optionee evidencing the terms and conditions of an individual Option grant.  Each Stock Option Agreement shall be subject to the terms and conditions of the Plan.

 

2.24   “Subsidiary” shall mean any corporation (other than the Corporation) in an unbroken chain of corporations beginning with the Corporation, provided each corporation (other than the last corporation) in the unbroken chain owns, at the time of the determination, stock possessing 50% or more of the total combined voting power of all class of stock in one of the other corporations in such chain.

 

2.25   “10% Stockholder” shall mean the owner of stock (as determined under Code § 424(d)) possessing more than 10% of the total combined voting power of all classes of stock of the Corporation (or any Parent or Subsidiary).

 

ARTICLE 3

PLAN ADMINISTRATION

3.1           Board.  The Plan shall be administered by the Board.  However, any or all administrative functions otherwise exercisable by the Board may be delegated to the Committee.  Members of the Committee shall serve for such period of time as the Board may determine and shall be subject to removal by the Board at any time.  The Board may also at any time terminate the functions of the Committee and reassume all powers and
authority previously delegated to the Committee.

3.2           Plan Administrator.  The Plan Administrator shall have full power and authority (subject to the provisions of the Plan) to establish such rules and regulations as it may deem appropriate for proper administration of the Plan and to make such determinations under, and issue such interpretations of, the Plan, Stock Option Agreements, and/or any outstanding Options thereunder as it may deem necessary or advisable.  Decisions of the Plan
Administrator shall be final and binding on all parties who have an interest in the Plan or any Stock Option Agreement issued thereunder.

ARTICLE 4

ELIGIBILITY

4.1           Participation.  The persons eligible to participate in the Plan are as follows:

  

4

  

(a)           Employees,

(b)           non-employee members of the Board, and

(c)           consultants, agents and other independent advisors who provide services to the Corporation (or any Parent or Subsidiary).

4.2           Incentive Options May Be Granted Only To Employees.  Incentive Options may be granted only to Employees.  Non-Statutory Options may be granted only to Employees, Board members, agents, consultants, and other independent advisors.  All Options actually granted to Board members, agents, consultants and other independent advisors shall be Non-Statutory Options.

4.3           More Than 10% Stockholders.  No person shall be eligible for the grant of an Incentive Option if, at the time of grant, such person is a 10% Stockholder, unless the exercise price of such Option is at least 110% of the Fair Market Value of such stock at the date of grant and the Option is not exercisable after the expiration of five years from the date of grant.

4.4           Authority of Plan Administrator Regarding Grants.  The Plan Administrator shall have full authority to determine, with respect to the grants made under the Plans: (i) which eligible persons are to receive such grants, (ii) the time or times when those grants are to be made, (iii) the number of shares to be covered by each such grant, (iv) the status of the granted Option as either an Incentive Option or a Non-Statutory Option, (v) the time or times when each Option is to
become exercisable, and (vi) the vesting schedule (if any) applicable to the Option shares and the maximum term for which the Option is to remain outstanding.

ARTICLE 5

STOCK SUBJECT TO THE PLAN

5.1           Number of Shares Issued Pursuant to Options.  Subject to the provisions of § 5.3 of the Plan, relating to adjustments upon changes in stock, the maximum number of shares that may be issued subject to the Plan shall be 5,000,000 shares.

5.2           Subsequent Issuance of Common Stock Subject to Outstanding Options.  Shares of Common Stock subject to outstanding Options shall be available for subsequent issuance under the Plan to the extent: (i) the Options expire or terminate for any reason prior to exercise in full, or (ii) the Options are cancelled in accordance with the cancellation/re-grant provisions of Article 9.  Shares issued under the Plan and subsequently repurchased by the Corporation pursuant to the Corporation’s
repurchase rights under the Plan shall be added back to the number of shares of Common Stock reserved for issuance under the Plan in the same category (i.e., Incentive Options, Non-statutory Options) and shall accordingly be available for reissuance through one or more subsequent Option grants under the Plan.

  

5

  

5.3           Change Affecting Outstanding Common Stock.  Should any change be made to the Common Stock by reason of any stock split, stock dividend, recapitalization, combination of shares, exchange of shares or other change affecting the outstanding Common Stock as a class without the Corporation’s receipt of consideration, appropriate adjustments shall be made, in order to prevent the dilution or enlargement of benefits thereunder, to: (i) the maximum number and/or class of securities issuable under the
Plan and (ii) the number and/or class of securities and the exercise price per share in effect under each outstanding Option.  The adjustments determined by the Plan Administrator shall be final, binding and conclusive.  In no event shall any such adjustments be made in connection with the conversion of one or more outstanding shares of the Corporation’s preferred stock into shares of Common Stock.

ARTICLE 6

OPTION GRANTS

6.1   Exercise Price.

(a) The exercise price per share shall be fixed by the Plan Administrator in accordance with the following provisions:

 

(i) The exercise price per share shall not be less than the Fair Market Value per share of Common Stock on the Option grant date.

 

(b)           The exercise price shall become immediately due upon exercise of the Option and shall, subject to § 10.1 of the Plan and the documents evidencing the Option, be payable in cash or check made payable to the Corporation.  Should the Common Stock be registered under Section 12 of the 1934 Act at the time the Option is exercised, then the exercise price may also be paid as follows:

 

(i)           in shares of Common Stock held for the requisite period necessary to avoid a charge to the Corporation’s earnings for financial reporting purposes and valued at Fair Market Value on the Exercise Date, or

 

(ii)           to the extent the Option is exercised for vested shares, through a special sale and remittance procedure pursuant to which the Optionee shall concurrently provide irrevocable instructions (A) to a Corporation designated brokerage firm to effect the immediate sale of the purchased shares and remit to the Corporation, out of the sale proceeds available on the settlement date, sufficient funds to cover the aggregate exercise price payable for the purchased shares plus all applicable Federal, state and local income and employment taxes required to be withheld by the Corporation by reason of such exercise, and (B) to the Corporation to deliver the
certificates for the purchased shares directly to such brokerage firm in order to complete the sale.

 

Except to the extent such sale and remittance procedure is utilized, payment of the exercise price for the purchased shares must be made on the Exercise Date.

 

  

6

  

6.2           Exercise and Term of Options.  Each Option shall be exercisable as determined by the Plan Administrator and as set forth in the documents evidencing the Option grant.  However, no Option shall have a term in excess of five years measured from the Option grant date.

 

6.3           Effect of Termination of Service.

 

(a)           The following provisions shall govern the exercise of any Options held by the Optionee at the time of cessation of Service or death:

(i)           Should the Optionee cease to remain in Service for any reason other than death, Disability or Misconduct, then the Optionee shall have a period of three (3) months following the date of such cessation of Service during which to exercise each outstanding Option held by such Optionee.

(ii)           Should Optionee’s Service terminate by reason of Disability, then the Optionee shall have a period of 12 months following the date of such cessation of Service during which to exercise each outstanding Option held by such Optionee.

(iii)           If the Optionee dies while holding an outstanding Option, then the personal representative of his or her estate or the person or persons to whom the Option is transferred pursuant to the Optionee’s will or the laws of inheritance shall have a 12 month period following the date of the Optionee’s death to exercise such Option.

(b)           Under no circumstances, however, shall any such Option be exercisable after the specified expiration of the Option term.

(i)           During the applicable post-Service exercise period, the Option may not be exercised in the aggregate for more than the number of vested shares for which the Option is exercisable on the date of the Optionee’s cessation of Service.  Upon the expiration of the applicable exercise period or (if earlier) upon the expiration of the Option term, the Option shall terminate and cease to be outstanding for any vested shares for which the Option has not been exercised.  However, the Option shall, immediately upon the Optionee’s cessation of Service, terminate and cease to be outstanding with respect to any and all Option
shares for which the Option is not otherwise at the time exercisable or in which the Optionee is not otherwise at that time vested.

(ii)           Should Optionee’s Service be terminated for Misconduct, then all outstanding Options held by the Optionee shall terminate immediately and cease to remain outstanding.

(c)           The Plan Administrator shall have the discretion, exercisable either at the time an Option is granted or at any time while the Option remains outstanding, to:

  

7

  

(i)           extend the period of time for which the Option is to remain exercisable following Optionee’s cessation of Service or death from the limited period otherwise in effect for that Option to such greater period of time as the Plan Administrator shall deem appropriate, but in no event beyond the expiration of the Option term, and/or

(ii)           permit the Option to be exercised, during the applicable post-Service exercise period, not only with respect to the number of vested shares of Common Stock for which such Option is exercisable at the time of the Optionee’s cessation of Service but also with respect to one or more additional installments in which the Optionee would have vested under the Option had the Optionee continued in Service.

6.4           Stockholder Rights.  The holder of an Option shall have no stockholder rights with respect to the shares subject to the Option until such person shall have exercised the Option, paid the exercise price and become the record holder of the purchased shares.

6.5           Repurchase of Shares.  Should the Optionee cease Service while holding vested shares, the Corporation shall have the right to repurchase at Fair Market Value, any or all of those vested shares.  The terms upon which such repurchase right shall be exercisable (including the period and procedure for exercise and the appropriate vesting schedule for the purchased shares) shall be established by the Plan Administrator and set forth in the document evidencing such repurchase right.

6.6           intentionally omitted

6.7           Limited Transferability of Options.  During the lifetime of the Optionee, the Option shall be exercisable only by the Optionee and shall not be assignable or transferable other than by will or by the laws of descent and distribution following the Optionee’s death.

ARTICLE 7

INCENTIVE OPTIONS

The terms specified below shall be applicable to all Incentive Options.  Except as modified by the provisions of this Article 7, all the provisions of the Plan shall apply to Incentive Options.  Options which are specifically designated as Non-Statutory Options shall not be subject to the terms of this Article 7.

7.1   Eligibility.  Incentive Options may only be granted to Employees.

  

8

  

7.2           Exercise Price.  The exercise price per share shall not be less than 100% of the Fair Market Value per share of Common Stock on the Option grant date.  However, if the person to whom the Incentive Option is granted is a 10% Stockholder, then the exercise price per share shall not be less than 110% of the Fair Market Value per share of Common Stock on the Option grant date.  Notwithstanding the foregoing, an Incentive Option may be granted with an exercise price lower than that set forth in the preceding sentence if such Incentive
Option is granted pursuant to an assumption or substitution for another Option in a manner satisfying the provisions of Code § 424(a) (involving a corporate reorganization).

7.3           Dollar Limitation.  The aggregate Fair Market Value of the shares of Common Stock (determined as of the respective date or dates of grant) for which one or more Options granted to any Employee under the Plan (or any other option plan of the Corporation or any Parent or Subsidiary) may for the first time become exercisable as Incentive Options during anyone one calendar year shall not exceed the sum of $100,000.  To the extent the Employee holds two or more such Options which become exercisable for the first time in the same calendar year, the
foregoing limitation on the exercisability of such Options as Incentive Options shall be applied on the basis of the order in which such Options are granted.

7.4           10% Stockholder.  If any Employee to whom an Incentive Option is granted is a 10% Stockholder, then the Option term shall not exceed five years measured from the Option grant date.

ARTICLE 8

CORPORATE TRANSACTION

8.1           Automatic Vesting of Shares Subject to Options.  The shares subject to each Option outstanding under the Plan at the time of a Corporate Transaction shall automatically vest in full so that each such Option shall, immediately prior to the effective date of the Corporate Transaction, become fully exercisable for all of the shares of Common Stock at the time subject to that Option and may be exercised for any or all of those shares as fully-vested shares of Common Stock.  However, the
shares subject to an outstanding Option shall not vest on such an accelerated basis if and to the extent: (i) such Option is assumed by the successor corporation (or parent thereof) in the Corporate Transaction and any repurchase rights of the Corporation with respect to the unvested Option shares are concurrently to be assigned to such successor corporation (or parent thereof), or (ii) such Option is to be replaced with a cash incentive program of the successor corporation which preserves the spread existing on the unvested Option shares at the time of the Corporate Transaction and provides for subsequent payout in accordance with the same vesting schedule applicable to those unvested Option shares, or (iii) the acceleration of such Option is subject to other limitations imposed by the Plan Administrator at the time of the Option grant.

  

9

  

8.2           Automatic Termination of Outstanding Repurchase Rights.  In the event of any Corporate Transaction, all outstanding repurchase rights shall terminate automatically, and the shares of Common Stock subject to those terminated rights shall immediately vest in full, except to the extent: (i) those repurchase rights are assigned to the successor corporation (or parent thereof) in connection with such Corporate Transaction, or (ii) such accelerated vesting is precluded by other limitations imposed
by the Plan Administrator at the time the repurchase right is issued.

8.3           Termination of Outstanding Options Following Corporate Transaction.  Immediately following the consummation of the Corporate Transaction, all outstanding Options shall terminate and cease to be outstanding, except to the extent assumed by the successor corporation (or parent thereof).

8.4           Adjustment of Options Assumed in Corporate Transaction.  Each Option which is assumed in connection with a Corporate Transaction shall be appropriately adjusted, immediately after such Corporate Transaction, to apply to the number and class of securities which would have been issuable to the Optionee in consummation of such Corporate Transaction, had the Option been exercised immediately prior to such Corporate Transaction.  Appropriate adjustments shall also be made to: (i) the number
and class of securities available for issuance under the Plan following the consummation of such Corporate Transaction, and (ii) the exercise price payable per share under each outstanding Option, provided the aggregate exercise price payable for such securities shall remain the same.

8.5           Plan Administrator’s Discretion to Automatically Accelerate or Fully Vest Options.  The Plan Administrator shall have the discretion, exercisable either at the time the Option is granted or at any time while the Option remains outstanding, to structure one or more Options so that those Options shall automatically accelerate and vest in full (and any repurchase rights of the Corporation with respect to the unvested shares subject to those Options shall immediately terminate) upon the
occurrence of a Corporate Transaction, whether or not those Options are to be assumed in the Corporate Transaction.

The Plan Administrator shall also have full power and authority, exercisable either at the time the Option is granted or at any time while the Option remains outstanding, to structure such Option so that the shares subject to that Option will automatically vest on an accelerated basis should the Optionee’s Service terminate by reason of an Involuntary Termination within a designated period (not to exceed 18 months) following the effective date of any Corporate Transaction in which the Option is assumed and the repurchase rights applicable to those shares do not otherwise terminate.  Any Option so accelerated shall remain exercisable for the fully-vested Option shares until the expiration or sooner
termination of the Option term.  In addition, the Plan Administrator may provide that one or more of the Corporation’s outstanding repurchase rights with respect to shares held by the Optionee at the time of such Involuntary Termination shall immediately terminate on an accelerated basis, and the shares subject to those terminated rights shall accordingly vest at that time.

 

  

10

  

8.6           Impact of $100,000 Limitation.  The portion of any Incentive Option accelerated in connection with a Corporate Transaction shall remain exercisable as an Incentive Option only to the extent the applicable $100,000 limitation is not exceeded.  To the extent such dollar limitation is exceeded, the accelerated portion of such Option shall be exercisable as a Non-Statutory Option under the Federal tax laws.

 

8.7           No Impact on Corporation’s Rights.  The grant of Options under the Plan shall in no way affect the right of the Corporation to adjust, reclassify, reorganize or otherwise change its capital or business structure or to merge, consolidate, dissolve, liquidate or sell or transfer all or any part of its business or assets.

 

ARTICLE 9

CANCELLATION AND RE-GRANT OF OPTIONS

The Plan Administrator shall have the authority to effect, at any time and from time to time, with the consent of the affected Option holders, the cancellation of any or all outstanding Options under the Plan and to grant in substitution therefore new Options covering the same or different number of shares of Common Stock but with an exercise price per share based on the Fair Market Value per share of Common Stock on the new Option grant date.

ARTICLE 10

MISCELLANEOUS

10.1   Effective Date and Term of Plan.

(a)           The Plan shall become effective when adopted by the Board.  If the Board determines to obtain shareholder approval of the Plan, such approval must be obtained within 12 months after the date of the Board’s adoption of the Plan. Notwithstanding the foregoing, the Plan Administrator may grant Options and issue shares under the Plan at any time after the effective date of the Plan and before the date fixed herein for termination of the Plan.

(b)           The Plan shall terminate upon the earliest of: (i) the expiration of the 10 year period measured from the date the Plan is adopted by the Board, (ii) the date on which all shares available for issuance under the Plan shall have been issued as vested shares, or (iii) the termination of all outstanding Options in connection with a Corporate Transaction.  All Options and unvested stock issuances outstanding at the time of a termination event under § 10.1(b)(i) of the Plan, shall continue to have full force and effect in accordance with the provisions of the documents evidencing those Options or issuances.

  

11

  

10.2   Amendment of the Plan.

(a)           The Board shall have complete and exclusive power and authority to amend or modify the Plan in any or all respects.  However, no such amendment or modification shall adversely affect the rights and obligations with respect to Options or unvested stock issuances at the time outstanding under the Plan unless the Optionee or the Participant consents to such amendment or modification.  In addition, certain amendments may require stockholder approval pursuant to applicable laws and regulations.

(b)           Options may be granted under the Plan which are in each instance in excess of the number of shares of Common Stock then available for issuance under the Plan, provided any excess shares actually issued under those programs shall be held in escrow until there is obtained stockholder approval of an amendment sufficiently increasing the number of shares of Common Stock available for issuance under the Plan.  If such stockholder approval is not obtained within 12 months after the date the first such excess grants or issuances are made, then: (i) any unexercised Options granted on the basis of such excess shares shall terminate and cease
to be outstanding, and (ii) the Corporation shall promptly refund to the Optionees and the Participants the exercise or purchase price paid for any excess shares issued under the Plan and held in escrow, together with interest (at the applicable short-term Federal rate) for the period the shares were held in escrow, and such shares shall thereupon be automatically cancelled and cease to be outstanding.

10.3           Use of Proceeds.  Any cash proceeds received by the Corporation from the sale of shares of Common Stock under the Plan shall be used for general corporate purposes.

10.4           Withholding.  The Corporation’s obligation to deliver shares of Common Stock upon the exercise of any Options granted under the Plan or upon the issuance or vesting of any shares issued under the Plan shall be subject to the satisfaction of all applicable Federal, state and local income and employment tax withholding requirements.

10.5           Regulatory Approvals.  The implementation of the Plan, the granting of any Options under the Plan, and the issuance of any shares of Common Stock upon the exercise of any Option shall be subject to the Corporation’s procurement of all approvals and permits required by regulatory authorities having jurisdiction over the Plan, the Options granted under it, and the shares of Common Stock issued pursuant to it.

10.6           No Employment or Service Rights.  Nothing in the Plan shall confer upon the Optionee or the Participant any right to continue in Service for any period of specific duration or interfere with or otherwise restrict in any way the rights of the Corporation (or any Parent or Subsidiary employing or retaining such person), the Optionee or the Participant, which rights are hereby expressly reserved by each, to terminate such person’s Service at any
time for any reason, with or without cause.

12

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00207-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00207-of-00352.parquet"}]]